Evidence map›Paper›PMID 37914993›Full record

ArticleBMC psychiatry2023

Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders.

Karam Chamoun, Joseph Mouawad, Pascale Salameh, Hala Sacre, Ramzi Haddad, Lydia Rabbaa Khabbaz, Bruno Megarbane, Aline Hajj

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Karam ChamounFaculty of Pharmacy, Saint Joseph University of Beirut, Beirut, Lebanon.
Joseph MouawadFaculty of Pharmacy, Saint Joseph University of Beirut, Beirut, Lebanon.
Pascale SalamehINSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie- Liban), Beirut, Lebanon.
Hala SacreINSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie- Liban), Beirut, Lebanon.
Ramzi HaddadPsychiatry Department, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Lydia Rabbaa KhabbazFaculty of Pharmacy, Saint Joseph University of Beirut, Beirut, Lebanon.
Bruno MegarbaneInserm, UMR-S1144, Université Paris Cité, Paris, France.
Aline HajjFaculty of Pharmacy, Saint Joseph University of Beirut, Beirut, Lebanon. aline.hajj@usj.edu.lb.
Saint Joseph University · LBHôpital Fernand-Widal · FRLebanese University · LBUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and validate the Arabic version of ORT-OUD in the Lebanese population and assess its clinical validity in a sample of patients with OUD.

methodsThis cross-sectional study in the Lebanese population used several validated scales to assess the risk of OUD, including the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Other tools evaluated chronotype and sleep and mood disturbances. Principal component analysis with Varimax rotation was applied to assess ORT-OUD construct validity. Convergent validity with the Arabic version of ASSIST was evaluated. The ORT-OUD criterion validity was then assessed in a clinical sample of patients with OUD.

resultsThis study included 581 participants. The prevalence of the OUD risk in the Lebanese population using the ORT-OUD scale and the ASSIST-opioids scale was estimated at 14.5% and 6.54%, respectively. No items of the ORT-OUD were removed; all items converged over a solution of four factors with an eigenvalue > 1, explaining a total of 68.2% of the variance (Cronbach's alpha = 0.648). The correlation coefficients between the ORT-OUD total score and ASSIST subscales were as follows: ASSIST-opioids (r = 0.174; p = < 0.001), ASSIST-sedatives (r = 0.249; p < 0.001), and ASSIST-alcohol (r = 0.161; p = < 0.001). ORT-OUD clinical validation showed a correlation with ASSIST-opioids (r = 0.251; p = 0.093) and ASSIST-sedatives (r = 0.598; p < 0.001). Higher ORT-OUD scores were associated with a family and personal history of alcohol and substance consumption and higher insomnia and anxiety scores.

conclusionsThis study is the first to validate the Arabic version of ORT-OUD in the Lebanese population, an essential step towards improving the detection and management of OUD in this population.

Indexed as

Mood DisordersOpioid-Related DisordersAnalgesics, OpioidCross-Sectional StudiesHumansHypnotics and SedativesReproducibility of ResultsSleepSurveys and QuestionnairesAnalgesics, OpioidHypnotics and SedativesArabicLebanonOpioid risk ToolOpioid use disorderScale validationSleep disorders

Identifiers

PMID37914993
PMCPMC10619223
OpenAlexW4388131713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.